<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12</volume><submitter>Li S</submitter><funding>Muséum National d&amp;apos;Histoire Naturelle</funding><pubmed_abstract>&lt;b>Background:&lt;/b> Heart failure (HF) is the end stage of ischemic cardiovascular diseases; nonetheless, safe and effective therapeutic agents for HF are still lacking, and their discovery remains challenging. Our previous studies demonstrated that Shen-Yuan-Dan Capsule (SYDC), a hospital preparation of traditional Chinese herbal, effectively protected ischemic injury in cardiovascular diseases. However, its therapeutic effects and possible mechanisms on HF remain unclear. &lt;b>Methods&lt;/b>: A zebrafish HF model treated with verapamil was developed to assess the therapeutic effect of SYDC on HF zebrafish. Zebrafish were administered with SYDC and digoxin (positive control) by direct soaking. After drug treatment, zebrafish were randomly assigned to the visual observation and image acquisition</pubmed_abstract><journal>Frontiers in pharmacology</journal><pagination>626515</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7959770</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Shen-Yuan-Dan Capsule Attenuates Verapamil-Induced Zebrafish Heart Failure and Exerts Antiapoptotic and Anti-Inflammatory Effects via Reactive Oxygen Species-Induced NF-κB Pathway.</pubmed_title><pmcid>PMC7959770</pmcid><pubmed_authors>Liu H</pubmed_authors><pubmed_authors>Zhou M</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Li S</pubmed_authors><pubmed_authors>Xing W</pubmed_authors><pubmed_authors>Qin X</pubmed_authors><pubmed_authors>Shang J</pubmed_authors><pubmed_authors>Gong Y</pubmed_authors><pubmed_authors>Li M</pubmed_authors><pubmed_authors>Liu W</pubmed_authors></additional><is_claimable>false</is_claimable><name>Shen-Yuan-Dan Capsule Attenuates Verapamil-Induced Zebrafish Heart Failure and Exerts Antiapoptotic and Anti-Inflammatory Effects via Reactive Oxygen Species-Induced NF-κB Pathway.</name><description>&lt;b>Background:&lt;/b> Heart failure (HF) is the end stage of ischemic cardiovascular diseases; nonetheless, safe and effective therapeutic agents for HF are still lacking, and their discovery remains challenging. Our previous studies demonstrated that Shen-Yuan-Dan Capsule (SYDC), a hospital preparation of traditional Chinese herbal, effectively protected ischemic injury in cardiovascular diseases. However, its therapeutic effects and possible mechanisms on HF remain unclear. &lt;b>Methods&lt;/b>: A zebrafish HF model treated with verapamil was developed to assess the therapeutic effect of SYDC on HF zebrafish. Zebrafish were administered with SYDC and digoxin (positive control) by direct soaking. After drug treatment, zebrafish were randomly assigned to the visual observation and image acquisition</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2025-04-26T00:44:18.61Z</modification><creation>2025-04-06T09:47:13.789Z</creation></dates><accession>S-EPMC7959770</accession><cross_references><pubmed>33732158</pubmed><doi>10.3389/fphar.2021.626515</doi></cross_references></HashMap>